<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32703469</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-9875</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Neurologic clinics</Title><ISOAbbreviation>Neurol Clin</ISOAbbreviation></Journal><ArticleTitle>ALS: Management Problems.</ArticleTitle><Pagination><StartPage>565</StartPage><EndPage>575</EndPage><MedlinePgn>565-575</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ncl.2020.03.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0733-8619(20)30034-7</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal disease with no cure; however, symptomatic management has an impact on quality of life and survival. Symptom management is best performed in a multidisciplinary care setting, where patients are evaluated by multiple health care professionals. Respiratory failure is a significant cause of morbidity and mortality in patients with ALS. Early initiation of noninvasive ventilation can prolong survival, and adequate use of airway clearance techniques can prevent respiratory infections. Preventing and treating weight loss caused by dysphagia may slow down disease progression, and expert management of spasticity from upper motor neuron dysfunction enhances patient well-being.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brent</LastName><ForeName>Jonathan R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL 60611, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franz</LastName><ForeName>Colin K</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Department of Neurology, Shirley Ryan AbilityLab, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coleman</LastName><ForeName>John M</ForeName><Initials>JM</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajroud-Driss</LastName><ForeName>Senda</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. Electronic address: s-ajroud@northwestern.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R25 NS070695</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurol Clin</MedlineTA><NlmUniqueID>8219232</NlmUniqueID><ISSNLinking>0733-8619</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="Y">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">Dysarthria</Keyword><Keyword MajorTopicYN="N">Dysphagia</Keyword><Keyword MajorTopicYN="N">Noninvasive ventilation</Keyword><Keyword MajorTopicYN="N">Respiratory failure</Keyword><Keyword MajorTopicYN="N">Secretion management</Keyword><Keyword MajorTopicYN="N">Sialorrhea</Keyword><Keyword MajorTopicYN="N">Spasticity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32703469</ArticleId><ArticleId IdType="mid">NIHMS1676129</ArticleId><ArticleId IdType="pmc">PMC7963888</ArticleId><ArticleId IdType="doi">10.1016/j.ncl.2020.03.013</ArticleId><ArticleId IdType="pii">S0733-8619(20)30034-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73(15):1218&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2764727</ArticleId><ArticleId IdType="pubmed">19822872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006;5(2):140&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16426990</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanayama K, Ishikawa Y, Bach JR. Amyotrophic lateral sclerosis. Successful treatment of mucous plugging by mechanical insufflation-exsufflation. Am J Phys Med Rehabil 1997;76(4):338&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9267195</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechtzin N, Wolfe LF, Frick KD. The impact of high-frequency chest wall oscillation on healthcare use in patients with neuromuscular diseases. Ann Am Thorac Soc 2016;13(6):904&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26999271</ArticleId></ArticleIdList></Reference><Reference><Citation>Boitano LJ. Management of airway clearance in neuromuscular disease. Respir Care 2006;51(8):913&#x2013;22 [discussion: 22&#x2013;4].</Citation><ArticleIdList><ArticleId IdType="pubmed">16867201</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CE, McVey AL, Rudnicki S, et al. Symptom management and end-of-life care in amyotrophic lateral sclerosis. Neurol Clin 2015;33(4):889&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5031364</ArticleId><ArticleId IdType="pubmed">26515628</ArticleId></ArticleIdList></Reference><Reference><Citation>Squires N, Humberstone M, Wills A, et al. The use of botulinum toxin injections to manage drooling in amyotrophic lateral sclerosis/motor neurone disease: a systematic review. Dysphagia 2014;29(4):500&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24847964</ArticleId></ArticleIdList></Reference><Reference><Citation>Assouline A, Levy A, Abdelnour-Mallet M, et al. Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients. Int J Radiat Oncol Biol Phys 2014;88(3):589&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">24411632</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 2014;10(11):661&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Korner S, Sieniawski M, Kollewe K, et al. Speech therapy and communication device: impact on quality of life and mood in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2013;14(1):20&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">22871079</ArticleId></ArticleIdList></Reference><Reference><Citation>Beukelman D, Fager S, Nordness A. Communication support for people with ALS. Neurol Res Int 2011;2011:714693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3096454</ArticleId><ArticleId IdType="pubmed">21603029</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanson EK, Beukelman DR, Yorkston KM. Communication support through multimodal supplementation: a scoping review. Augment Altern Commun 2013;29(4): 310&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">24229335</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownlee A, Palovcak M. The role of augmentative communication devices in the medical management of ALS. NeuroRehabilitation 2007;22(6):445&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">18198430</ArticleId></ArticleIdList></Reference><Reference><Citation>Plowman EK. Is there a role for exercise in the management of bulbar dysfunction in amyotrophic lateral sclerosis? J Speech Lang Hear Res 2015;58(4):1151&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">26091205</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Truong TC, et al. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999;53(5):1059&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Desport JC, Kajeu P, et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2011;82(6):628&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Ludolph AC, Huebers A. Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther Adv Neurol Disord 2018;11. 1756285617734734.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784546</ArticleId><ArticleId IdType="pubmed">29399045</ArticleId></ArticleIdList></Reference><Reference><Citation>ProGas Study Group. Gastrostomy in patients with amyotrophic lateral sclerosis (ProGas): a prospective cohort study. Lancet Neurol 2015;14(7):702&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4578147</ArticleId><ArticleId IdType="pubmed">26027943</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Shi X. Percutaneous endoscopic gastrostomy versus fluoroscopic gastrostomy in amyotrophic lateral sclerosis (ALS) sufferers with nutritional impairment: a meta-analysis of current studies. Oncotarget 2017;8(60):102244&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5731950</ArticleId><ArticleId IdType="pubmed">29254240</ArticleId></ArticleIdList></Reference><Reference><Citation>EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, Andersen PM, Abrahams S, Borasio GD, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;revised report of an EFNS task force. Eur J Neurol 2012;19(3):360&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Arciniegas DB, Brooks BR, et al. Defining and diagnosing involuntary emotional expression disorder. CNS Spectr 2006;11(S6):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16816786</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher JP. Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand 1989;80(2):114&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2816272</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer R, Pope LE. Review of pseudobulbar affect including a novel and potential therapy. J Neuropsychiatry Clin Neurosci 2005;17(4):447&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">16387982</ArticleId></ArticleIdList></Reference><Reference><Citation>Finegan E, Chipika RH, Li Hi Shing S, et al. Pathological crying and laughing in motor neuron disease: pathobiology, screening, intervention. Front Neurol 2019; 10:260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6438102</ArticleId><ArticleId IdType="pubmed">30949121</ArticleId></ArticleIdList></Reference><Reference><Citation>Pioro EP, Brooks BR, Cummings J, et al. Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affect. Ann Neurol 2010;68(5):693&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pubmed">20839238</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith R, Pioro E, Myers K, et al. Enhanced bulbar function in amyotrophic lateral sclerosis: the nuedexta treatment trial. Neurotherapeutics 2017;14(3):762&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5509619</ArticleId><ArticleId IdType="pubmed">28070747</ArticleId></ArticleIdList></Reference><Reference><Citation>Green JR, Allison KM, Cordella C, et al. Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis. Br J Clin Pharmacol 2018;84(12):2849&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6256051</ArticleId><ArticleId IdType="pubmed">30152872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987;67(2):206&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">3809245</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayadev AS, Weiss MD, Distad BJ, et al. The amyotrophic lateral sclerosis center: a model of multidisciplinary management. Phys Med Rehabil Clin N Am 2008; 19(3):619&#x2013;31, xi.</Citation><ArticleIdList><ArticleId IdType="pubmed">18625420</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha JA, Reis C, Simoes F, et al. Diagnostic investigation and multidisciplinary management in motor neuron disease. J Neurol 2005;252(12):1435&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">16362828</ArticleId></ArticleIdList></Reference><Reference><Citation>Utili R, Boitnott JK, Zimmerman HJ. Dantrolene-associated hepatic injury. Incidence and character. Gastroenterology 1977;72(4 Pt 1):610&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">838213</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>